Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURMODICS INC Director's Dealing 2019

Feb 5, 2019

32845_dirs_2019-02-05_2b8b78c6-f587-40ef-99ee-dee443965c66.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-10-01

Reporting Person: Maharaj Gary R (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-10-01 Common Stock S 4100 $72.0366 Disposed 170767 Direct
2018-10-01 Common Stock S 200 $72.75 Disposed 170567 Direct
2018-10-01 Common Stock S 700 $74.1043 Disposed 169867 Direct
2019-02-01 Common Stock S 668 $51.8681 Disposed 169199 Direct
2019-02-01 Common Stock S 925 $53.0502 Disposed 168274 Direct
2019-02-01 Common Stock S 840 $54.049 Disposed 167434 Direct
2019-02-01 Common Stock S 300 $55.53 Disposed 167134 Direct
2019-02-01 Common Stock S 100 $56.36 Disposed 167034 Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.

F2: Reflects the weighted average price of 4,100 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $71.38 to $72.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reflects the weighted average price of 200 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $72.56 to $72.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Reflects the weighted average price of 700 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on October 1, 2018 with sale prices ranging from $74.00 to $74.29 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F5: Reflects the weighted average price of 668 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $51.561 to $52.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F6: Reflects the weighted average price of 925 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $52.75 to $53.675 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F7: Reflects the weighted average price of 840 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $53.805 to $54.33 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F8: Reflects the weighted average price of 300 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2019 with sale prices ranging from $54.885 to $55.865 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.